Haronga bark and leaf
Harunganae madagascariensis cortex et folium
Harongarinde und bltter
Published March 13, 1990
Name of Drug
Harunganae madagascariensis cortex et folium, haronga bark and leaf.
Composition of Drug
Haronga bark with dried leaves consists of the bark and leaves of Harungana madagascariensis Lamarck ex Poiret [Fam. Hypericaceae], as well as its preparations in effective dosage.
The bark contains 1,8-dihydroxyanthracene derivatives, such as harunganin and madagascin.
The leaf contains dimers of 1,8-dihydroxyanthracene derivatives, such as hypericin and pseudohypericin.
Dyspepsia, mild exocrine pancreatic insufficiency.
Acute pancreatitis and acute attacks of chronic recurring pancreatitis, severe liver function disorders, gallstones, obstruction of bile ducts, gall bladder empyema, ileus.
Warning:Photosensitivity is especially possible in fair-skinned individuals.
Interactions with Other Drugs
Unless otherwise prescribed:
Average daily dosage:
Mode of Administration
- 7.5 - 15 mg of an aqueous-alcoholic dry extract corresponding to 25 - 50 mg drug;
- equivalent preparations.
Preparations of haronga bark with leaves for oral use.
Duration of Administration
Preparations of haronga bark with leaves must not be taken longer than 2 months.
Stimulation of the excretory function of the pancreas
Stimulation of the gastric juice secretion